Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2%pirenzepineophthalmicgelinchildrenwithmyopia
- 31 August 2008
- journal article
- research article
- Published by Elsevier BV in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 12 (4), 332-339
- https://doi.org/10.1016/j.jaapos.2007.10.014
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inferring myopia over the lifecourse from uncorrected distance visual acuity in childhoodBritish Journal of Ophthalmology, 2007
- One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopiaOphthalmology, 2005
- A Tolerability Study of Pirenzepine Ophthalmic Gel in Myopic ChildrenJournal of Ocular Pharmacology and Therapeutics, 2003
- MyopiaBMJ, 2002
- Interventions to retard myopia progression in children: an evidence-based updateOphthalmology, 2002
- Effects of Different Concentrations of Atropine on Controlling Myopia in Myopic ChildrenJournal of Ocular Pharmacology and Therapeutics, 1999
- Pirenzepine prevents form deprivation myopia in a dose dependent mannerOphthalmic and Physiological Optics, 1995
- Lid-suture myopia in tree shrews with retinal ganglion cell blockadeVisual Neuroscience, 1994
- Developing eyes that lack accommodation grow to compensate for imposed defocusVisual Neuroscience, 1990
- Pirenzepine A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in Peptic Ulcer Disease and Other Allied DiseasesDrugs, 1985